Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
01/2003
01/03/2003CA2450921A1 Protein modification and maintenance molecules
01/03/2003CA2449990A1 Type 1 diabetes diagnostics and therapeutics
01/03/2003CA2448222A1 Culture apparatus and cultivation method
01/02/2003US20030005489 Regeneration system for grape and uses thereof
01/02/2003US20030005480 Stress resistant plant in which cell death suppressing gene is introduced and method for producing the same
01/02/2003US20030005478 Methods
01/02/2003US20030005470 Animal model for use in the diagnosis and treatment of tumors and bone matastasis
01/02/2003US20030004327 Cerebellum and embryo specific protein
01/02/2003US20030004324 31 human secreted proteins
01/02/2003US20030004317 Nucleic acids encoding anti-human alphanubeta3 and alphanubeta5 antibodies
01/02/2003US20030004310 Culture product
01/02/2003US20030004306 Fluorescent protein
01/02/2003US20030004133 Wound healing agents, antiulcer agents
01/02/2003US20030004106 Interleukin-1 receptor antagonist-related molecules and uses thereof
01/02/2003US20030004102 Genetic engineering; immunosuppressants, anticancer agents
01/02/2003US20030004095 Treatment of diabetes with milk protein hydrolysate
01/02/2003US20030004065 Electrically generated silver ions to control plant disease; bactericides; fungicides, viricides; algicides; irrigation; water treatment; electrical anodic corrosion of a silver wire in aqueous medium
01/02/2003US20030003581 Method for targeting transcriptionally active loci
01/02/2003US20030003579 Dendritic cells; methods
01/02/2003US20030003576 Peripheral blood fibrocytes differentiation pathway and migration to wound sites
01/02/2003US20030003575 Apparatus for use in the generation of thin layered films
01/02/2003US20030003574 Multipotent stem cells from peripheral tissues and uses thereof
01/02/2003US20030003573 Cells for use in the treatment of liver disorders
01/02/2003US20030003572 Propagation of preefrential nercous system tissue; obtain cells, inoculate nutrient broth containing nerve growth factor, propagate and recover cells
01/02/2003US20030003567 Packaging cells
01/02/2003US20030003566 Cell line preparing and producing ovine adenovirus vectors
01/02/2003US20030003555 Nucleotide sequences coding proteins for use in the diagnosis and treatment of hematopoietic or immune disorders
01/02/2003US20030003554 Generation of preferential solid support; obtain chemical intermediates, incubate with reaction mixture, immerse in thin film, dry, recover support
01/02/2003US20030003546 Treating degenerative cartilaginous disorders and other inflammatory diseases
01/02/2003US20030003545 Nucleotide sequences coding polypeptide for use in the treatment of immunological defects
01/02/2003US20030003543 Methods and applications for efficient genetic suppressor elements
01/02/2003US20030003542 ACPL polypeptides
01/02/2003US20030003541 Nucleotide sequences coding peptide for use in the treatment of skin, brain and eye disorders
01/02/2003US20030003538 Neuropathic pain genes; compositions thereof; related reagents
01/02/2003US20030003536 Vanilloid receptor
01/02/2003US20030003535 Single chain class I major histo-compatibility complexes
01/02/2003US20030003532 Novel nucleic acid sequences encoding human slit-, megf-, and roundabout-like polypeptides
01/02/2003US20030003531 Secreted and transmembrane polypeptides and nucleic acids encoding the same
01/02/2003US20030003530 Nucleotide sequences coding protein for use in diagnosis and treatment of skin and cancer disorders
01/02/2003US20030003508 Serological diagnostic method with rickettsia pulicis bacterium
01/02/2003US20030003478 Identifying and characterizing genes
01/02/2003US20030003477 Nucleotide sequences coding polypeptides for use in the treatment of nervous system, kidney, muscle, allergic and cancer disorders
01/02/2003US20030003472 Detection of genetic aberration in sample; obtain nucleotide sequences, incubate with oligonucleotides, detect aberration in hybridization, presence of aberration indicates variablity in nucleotide sequences
01/02/2003US20030003466 Artificial mammalian chromosome
01/02/2003US20030003462 Novel human interleukin-like proteins and polynucleotides encoding them
01/02/2003US20030003452 Polymerase for use in the treatment of infections, respiratory, blood, alzheimer's, muscular and cancerous disorders
01/02/2003US20030003448 Method
01/02/2003US20030003447 Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus
01/02/2003US20030003443 Designation MVP-5180/91, deposited with the European Collection of Animal Cell Cultures under No V 920 92 318
01/02/2003US20030003442 Retrovirus from the HIV group and its use
01/02/2003US20030003164 Use of dictyotal extracts in the production of a topical composition
01/02/2003US20030003098 Treating graft with molecule which binds to co-stimulatory protein of antigen-presenting cells
01/02/2003US20030003097 Recombinant antibodies coexpressed with GnTIII
01/02/2003US20030003090 Increasing the intracellular level of cyclic AMP; treating a human patient having a disease, condition, or disorder of the central nervous system
01/02/2003US20030003089 Cells organized on a support to provide a three-dimensional cell structure; used for research or drug testing, in surgical implantation for the treatment of heart disease
01/02/2003US20030003088 A human pancreatic ductal cell line immortalized with human papilloma virus genes E6 and E7 and which is capable of produce insulin; treating insulin-dependent diabetes; determining a chemical agent to induce cell differentiation
01/02/2003US20030003087 Use of marrow-derived glial progenitor cells as gene delivery vehicles into the central nervous system
01/02/2003US20030003086 A genetic engineered cell comprising an exogenously derived nucleic acid coding for a thimet oligopeptidase (TOP) polypeptide; modulate antigen presentation on cell surfaces, works synergistically with immunosuppressive drugs
01/02/2003US20030003085 Drug delivery of a muscle protein by administering purified donor muscle side population cells; gene therapy, in the treatment muscle diseases muscular dystrophies, genetic diseases, treating cancer, and bone marrow transplant
01/02/2003US20030003084 Human mesenchymal progenitor cell
01/02/2003US20030003083 Administering a dose of non- alloreactive anti-third party cytotoxic T-lymphocytes (CTLs), which were generated by directing T-lymphocytes of the donor against a third party antigen or antigens
01/02/2003EP1271153A2 Collapsin response mediator protein-1 as tumor metastasis marker
01/02/2003EP1270744A1 Reporter gene construct for the detection of HIV rev and HIV tat
01/02/2003EP1270741A1 Nucleotide sequences involved in plant disease resistance
01/02/2003EP1270732A1 Improved transfection of eukaryontic cells with linear polynucleotides by electroporation
01/02/2003EP1270727A1 Salutaridinol 7-O-acetyltransferase and derivatives thereof
01/02/2003EP1270720A2 Activated rec-D-Hydantoinases
01/02/2003EP1270719A2 Cell population containing non-fetal hemangioblasts and method for producing same
01/02/2003EP1270718A1 Cell culturing method and device
01/02/2003EP1270593A2 HSCA-3 antigen and monoclonal antibody which recognizes the antigen
01/02/2003EP1270591A1 Transgenic cells and a method for detecting disruptors for androgens by using said transgenic cells
01/02/2003EP1270590A1 Human CD24-like protein and nucleic acids encoding it
01/02/2003EP1270588A1 Novel collagen-like protein clac, precursor thereof and genes encoding the same
01/02/2003EP1270533A2 Ceramic materials, method for their production and use thereof
01/02/2003EP1268836A2 Novel sperm-dna complexes for genetically modifying non-human animals
01/02/2003EP1268835A1 Retinoic acid receptor beta-2, its antagonists, and gene therapy vectors for the treatment of neurological disorders
01/02/2003EP1268820A2 Estrogen-regulated myo-inositol phosphate synthase: compositions and methods of use
01/02/2003EP1268819A2 Muskmelon (cucumis melo) hydroperoxide lyase and uses thereof
01/02/2003EP1268817A1 Human pyruvate dehydrogenese phosphatase
01/02/2003EP1268816A2 Calcium-binding regulatory subunit
01/02/2003EP1268813A2 Thermophilic polymerase iii holoenzyme
01/02/2003EP1268812A2 Vectors for gene therapy
01/02/2003EP1268802A2 Beta-like glycoprotein hormone polypeptide and heterodimer
01/02/2003EP1268799A2 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability
01/02/2003EP1268798A2 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains
01/02/2003EP1268797A2 Compositions and methods for the therapy and diagnosis of lung cancer
01/02/2003EP1268796A1 Identification of human gaba transporter
01/02/2003EP1268793A2 Fibroblast growth factor receptor-like molecules and uses thereof
01/02/2003EP1268792A2 Wnt-7b-like polypeptides and nucleic acids encoding same
01/02/2003EP1268790A1 Gene coding for erbin, and diagnostic and therapeutic uses thereof
01/02/2003EP1268787A2 Human tap-like protein (transporter associated in antigen processing/presentation)
01/02/2003EP1268785A2 Gtp-binding protein gamma-12 subunit
01/02/2003EP1268784A2 Genes involved in intestinal inflammatory diseases and use thereof
01/02/2003EP1268783A2 Anti-angiogenic and anti-tumor properties of matin and other laminin domains
01/02/2003EP1268782A2 Apolipoprotein-a-i regulation of t-cell signalling
01/02/2003EP1268781A2 G12l, a gene associated with the thermal response
01/02/2003EP1268778A1 Materials and methods relating to a novel splice variant of a na + dependent glutamate transporter
01/02/2003EP1268775A1 The high bone mass gene of 11q13.3
01/02/2003EP1268773A1 Immune system-related polynucleotides, polypeptides, and antibodies
01/02/2003EP1268772A2 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system